Point72 Asset Management, L.P. - 17 Oct 2025 SCHEDULE 13G Report for C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- CCCC
- Shares outstanding
- 228,764,111 shares
- Disclosed Ownership
- 22,647,647 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Oct 2025, 17:58:54 UTC
- Date of event
- 17 Oct 2025
- SEC
- View on sec.gov
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 9.9% | 22,647,647 | 0 | 22,647,647 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 9.9% | 22,647,647 | 0 | 22,647,647 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 9.9% | 22,647,647 | 0 | 22,647,647 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |